Search

everythinglearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

HuR is essential for Treg function and preventing autoimmunity.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Thymoma with alopecia areata may be linked to abnormal immune cells.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Restoring hair follicle immune privilege may help treat alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

The skin's immune system helps it regenerate and fight infections.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Vitiligo and alopecia areata may have similar causes despite their differences.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.